PATH | VRL
Menu

Rotavirus Disease in Uzbekistan: Cost-Effectiveness of a New Vaccine

Investigators estimated the costs related to rotavirus disease in Uzbekistan and determined that a vaccine would be cost-effective, while also drastically reducing hospitalizations and deaths. This article was published in the journal Vaccine.

Author: Isakbaeva E, Musabaevc E, Antil L, et al.

Published: 2007

» Download file (Russian)

161 KB PDF

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Isakbaeva E, Musabaev E, Antil L, et al. Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine. Vaccine. 2007;25(2):373-380.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Immunization financing, Disease/vaccine specific information

Regions: Eastern Europe